1. Home
  2. PMVP vs NTRB Comparison

PMVP vs NTRB Comparison

Compare PMVP & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • NTRB
  • Stock Information
  • Founded
  • PMVP 2013
  • NTRB 2016
  • Country
  • PMVP United States
  • NTRB United States
  • Employees
  • PMVP N/A
  • NTRB N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • NTRB Industrial Specialties
  • Sector
  • PMVP Health Care
  • NTRB Health Care
  • Exchange
  • PMVP Nasdaq
  • NTRB Nasdaq
  • Market Cap
  • PMVP 77.4M
  • NTRB 71.8M
  • IPO Year
  • PMVP 2020
  • NTRB N/A
  • Fundamental
  • Price
  • PMVP $1.29
  • NTRB $7.15
  • Analyst Decision
  • PMVP Strong Buy
  • NTRB Buy
  • Analyst Count
  • PMVP 1
  • NTRB 1
  • Target Price
  • PMVP $5.00
  • NTRB $13.00
  • AVG Volume (30 Days)
  • PMVP 2.6M
  • NTRB 32.3K
  • Earning Date
  • PMVP 11-06-2025
  • NTRB 09-09-2025
  • Dividend Yield
  • PMVP N/A
  • NTRB N/A
  • EPS Growth
  • PMVP N/A
  • NTRB N/A
  • EPS
  • PMVP N/A
  • NTRB N/A
  • Revenue
  • PMVP N/A
  • NTRB $2,578,059.00
  • Revenue This Year
  • PMVP N/A
  • NTRB $560.75
  • Revenue Next Year
  • PMVP N/A
  • NTRB $588.39
  • P/E Ratio
  • PMVP N/A
  • NTRB N/A
  • Revenue Growth
  • PMVP N/A
  • NTRB 42.92
  • 52 Week Low
  • PMVP $0.81
  • NTRB $2.98
  • 52 Week High
  • PMVP $1.84
  • NTRB $9.42
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 45.65
  • NTRB 57.39
  • Support Level
  • PMVP $1.12
  • NTRB $6.69
  • Resistance Level
  • PMVP $1.40
  • NTRB $7.48
  • Average True Range (ATR)
  • PMVP 0.16
  • NTRB 0.44
  • MACD
  • PMVP -0.03
  • NTRB 0.15
  • Stochastic Oscillator
  • PMVP 23.50
  • NTRB 80.26

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: